secwatch.observer — SEC 8-K summary
======================================

Issuer:     ORAMED PHARMACEUTICALS INC. (ORMP)
CIK:        0001176309
Form:       8-K
Filed at:   2024-08-02T23:59:59+00:00
Accession:  0001213900-24-064732
Event type: other_material
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Oramed shareholders re-elect all seven directors, approve say-on-pay, ratify auditor at 2024 annual meeting
--------------------------------------------------------------------------------

- All seven director nominees re-elected with majority votes; top vote-getter Benjamin Shapiro had 10,120,322 for.
- Advisory vote on executive compensation passed: 9,171,779 for, 1,016,334 against.
- Ratification of Kesselman & Kesselman (PwC Israel) as FY 2024 auditor approved: 17,323,361 for.
- Broker non-votes of 7,236,740 on director elections and say-on-pay due to lack of discretionary voting.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1176309/000121390024064732/0001213900-24-064732-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1176309/000121390024064732/ea0210492-8k_oramed.htm
  HTML page:      https://secwatch.observer/filing/0001213900-24-064732

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer